North America Gastric Cancer Diagnostics Market to 2032
Overview
The North America Gastric Cancer Diagnostics Market is expected to reach a 864.69 USD Million by 2032 and is projected to grow at a CAGR of 10.12% from 2025 to 2032.
Revenue, 2024 (USD Million)
497.49
Forecast, 2032 (USD Million)
864.69
CAGR, 2024 - 2032
10.12%
Report Coverage
North America
North America Gastric Cancer Diagnostics Market 2018-2032 USD Million
North America Gastric Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 497.49 USD Million
- Projected Market Size (2032): 864.69 USD Million
- CAGR (2025-2032): 10.12%
Key Findings of North America Gastric Cancer Diagnostics Market
- The North America Gastric Cancer Diagnostics Market was valued at 497.49 USD Million in 2024.
- The North America Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 10.12% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 316.42 USD Million
- The fastest growing segment Stool in Sample Type Segment grew Fastest with a CAGR of 13.13% during the forecast period from 2024 to 2032.
North America Gastric Cancer Diagnostics Market Scope
North America Gastric Cancer Diagnostics Market Segmentation & Scope
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Sample Type
- Urine
- Blood
- Tissue
- Stool
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Age Group
- pediatric
- Adult
- Geriatrics
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
North America Gastric Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 497.49 USD Million |
| Market Value in 2032 | 864.69 USD Million |
| CAGR (2025-2032) | 10.12% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 497.49 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 429.75 USD Million in 2024.
Segments and Scope
-
North America Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 182.98 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.05 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 316.42 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.11 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 201.81 USD Million in the year 2024.
- Stool is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.13 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 176.24 USD Million in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.74 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 186.76 USD Million in the year 2024.
- Stage I is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.62 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 266.59 USD Million in the year 2024.
- Male is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.02 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 266.34 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.34 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 277.51 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 12.04 % in forecast period 2025-2032.
-
North America Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in North America Gastric Cancer Diagnostics Market to 2032 with a revenue of 287.14 USD Million in the year 2024.
- Confirmatory Test is the Fastest growing segment in North America Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.14 % in forecast period 2025-2032.
North America Gastric Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| BIOMÉRIEUX | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
North America Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
North America Gastric Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Gastric Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type.
North America Gastric Cancer Diagnostics Market was valued at USD 497.49(Revenue in USD Million) in 2020.
North America Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 10.12% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the North America Gastric Cancer Diagnostics Market, holding a largest market share of 316.42 USD Million in 2024
North America Gastric Cancer Diagnostics Market Scope
North America Gastric Cancer Diagnostics Market Segmentation & Scope
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Sample Type
- Urine
- Blood
- Tissue
- Stool
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Age Group
- pediatric
- Adult
- Geriatrics
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Frequently Asked Questions
The North America Gastric Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type.
North America Gastric Cancer Diagnostics Market was valued at USD 497.49(Revenue in USD Million) in 2020.
North America Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 10.12% during the forecast period of 2024 to 2032.
The estimated market value of the North America Gastric Cancer Diagnostics Market for final year is USD 864.69 (USD Million).
North America Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The North America Gastric Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type.
North America Gastric Cancer Diagnostics Market was valued at USD 497.49(Revenue in USD Million) in 2020.
North America Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 10.12% during the forecast period of 2024 to 2032.
The estimated market value of the North America Gastric Cancer Diagnostics Market for final year is USD 864.69 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.